0001628280-21-018595.txt : 20210914
0001628280-21-018595.hdr.sgml : 20210914
20210914171223
ACCESSION NUMBER: 0001628280-21-018595
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210910
FILED AS OF DATE: 20210914
DATE AS OF CHANGE: 20210914
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Huizinga Robert Bindert
CENTRAL INDEX KEY: 0001837648
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36421
FILM NUMBER: 211253151
MAIL ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA
STATE: A1
ZIP: BC V8Z7X8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aurinia Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001600620
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA BC
STATE: A1
ZIP: V8Z 7X8
BUSINESS PHONE: 250-708-4272
MAIL ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA BC
STATE: A1
ZIP: V8Z 7X8
4
1
wf-form4_163165391729313.xml
FORM 4
X0306
4
2021-09-10
0
0001600620
Aurinia Pharmaceuticals Inc.
AUPH
0001837648
Huizinga Robert Bindert
#1203-4464 MARKHAM STREET
VICTORIA
A1
V8Z7X8
BRITISH COLUMBIA, CANADA
0
1
0
0
EVP of Research
Common Stock
2021-09-10
4
S
0
5000
19.83
D
133592
D
Common Stock
2021-09-10
4
S
0
5000
19.76
D
128592
D
Common Stock
2021-09-14
4
S
0
22500
21.75
D
106092
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
/s/ Robert Bindert Huizinga
2021-09-14